All In MedTech

FDA Clearance Tracker · P990025-S007

NAVISTAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 10, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 10, 2002

Approved

Time to decision

18 days

Received Aug 23, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P990025-S007
Device name
NAVISTAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
Applicant location
Irvine, CA
Received
Aug 23, 2002
Decided
Sep 10, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Express GMP Supplement
Original approval
P990025

Device type

Device class
Class II
Regulation
21 CFR 870.1220
Specialty
Cardiology

Every decision under product code DRF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN ALTERNATE MANUFACTURING FACILITY LOCATED AT BIOSENSE WEBSTER, INC., CHIHUAHUA, MEXICO.

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.